Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $24,947 | 8 | 95.6% |
| Travel and Lodging | $788.80 | 3 | 3.0% |
| Food and Beverage | $371.78 | 3 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $21,166 | 7 | $0 (2021) |
| Varian Medical Systems, Inc. | $4,421 | 3 | $0 (2019) |
| IBA Proton Therapy, Inc. | $253.00 | 1 | $0 (2018) |
| Ion Beam Applications S.A. | $249.05 | 2 | $0 (2017) |
| ABBVIE INC. | $18.85 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $18.85 | 1 | ABBVIE INC. ($18.85) |
| 2021 | $16,636 | 6 | AstraZeneca Pharmaceuticals LP ($16,636) |
| 2019 | $8,312 | 2 | AstraZeneca Pharmaceuticals LP ($4,530) |
| 2018 | $892.68 | 3 | Varian Medical Systems, Inc. ($639.68) |
| 2017 | $249.05 | 2 | Ion Beam Applications S.A. ($249.05) |
All Payment Transactions
14 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/16/2024 | ABBVIE INC. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: ONCOLOGY | ||||||
| 12/05/2021 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Consulting Fee | Cash or cash equivalent | $2,642.50 | General |
| Category: Oncology | ||||||
| 11/15/2021 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Consulting Fee | Cash or cash equivalent | $3,397.50 | General |
| Category: Oncology | ||||||
| 11/15/2021 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Consulting Fee | Cash or cash equivalent | $2,642.50 | General |
| Category: Oncology | ||||||
| 10/21/2021 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Consulting Fee | Cash or cash equivalent | $3,800.00 | General |
| Category: Oncology | ||||||
| 06/21/2021 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Consulting Fee | Cash or cash equivalent | $1,888.00 | General |
| Category: Oncology | ||||||
| 01/06/2021 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Consulting Fee | Cash or cash equivalent | $2,265.00 | General |
| Category: Oncology | ||||||
| 08/08/2019 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Consulting Fee | Cash or cash equivalent | $4,530.00 | General |
| Category: Oncology | ||||||
| 04/29/2019 | Varian Medical Systems, Inc. | OTHER (Device) | Consulting Fee | Cash or cash equivalent | $3,781.59 | General |
| Category: Devices | ||||||
| 12/12/2018 | Varian Medical Systems, Inc. | TrueBeam (Device) | Travel and Lodging | In-kind items and services | $406.48 | General |
| Category: Devices | ||||||
| 12/12/2018 | Varian Medical Systems, Inc. | TrueBeam (Device) | Travel and Lodging | In-kind items and services | $233.20 | General |
| Category: Devices | ||||||
| 05/25/2018 | IBA Proton Therapy, Inc. | — | Food and Beverage | Cash or cash equivalent | $253.00 | General |
| 03/20/2017 | Ion Beam Applications S.A. | — | Travel and Lodging | Cash or cash equivalent | $149.12 | General |
| Category: Proton Therapy | ||||||
| 03/20/2017 | Ion Beam Applications S.A. | — | Food and Beverage | Cash or cash equivalent | $99.93 | General |
| Category: Proton Therapy | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 185 | 403 | $133,010 | $34,490 |
| 2022 | 2 | 75 | 90 | $10,425 | $2,791 |
| 2021 | 14 | 448 | 597 | $154,262 | $46,485 |
| 2020 | 18 | 967 | 1,404 | $416,598 | $115,495 |
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 77427 | Radiation treatment management, 5 treatment sessions | Facility | 2023 | 14 | 53 | $31,800 | $8,491 | 26.7% |
| 77301 | High precision radiation therapy planning | Facility | 2023 | 21 | 21 | $27,720 | $7,354 | 26.5% |
| 77014 | Ct guidance for insertion of radiation therapy fields | Facility | 2023 | 31 | 107 | $16,050 | $3,992 | 24.9% |
| 77338 | Design and construction of radiation treatment device for high precision radiation therapy | Facility | 2023 | 21 | 21 | $14,910 | $3,945 | 26.5% |
| 77263 | Complex radiation therapy planning | Facility | 2023 | 23 | 23 | $12,190 | $3,130 | 25.7% |
| 77300 | Calculation of radiation therapy dose | Facility | 2023 | 22 | 109 | $11,990 | $3,000 | 25.0% |
| 77334 | Design and construction of complex radiation treatment device | Facility | 2023 | 23 | 39 | $8,190 | $1,930 | 23.6% |
| 77293 | Obtaining respiratory data needed to develop the optimal radiation treatment | Facility | 2023 | 17 | 17 | $5,610 | $1,487 | 26.5% |
| 77470 | Special radiation treatment | Facility | 2023 | 13 | 13 | $4,550 | $1,160 | 25.5% |
| 77014 | Ct guidance for insertion of radiation therapy fields | Facility | 2022 | 28 | 33 | $4,620 | $1,240 | 26.8% |
| 77014 | Ct guidance for insertion of radiation therapy fields | Office | 2022 | 21 | 28 | $3,920 | $1,058 | 27.0% |
| G6002 | Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy | Office | 2022 | 14 | 17 | $1,105 | $289.68 | 26.2% |
| G6002 | Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy | Facility | 2022 | 12 | 12 | $780.00 | $203.54 | 26.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 59 | 68 | $16,116 | $8,015 | 49.7% |
| 77427 | Radiation treatment management, 5 treatments | Facility | 2021 | 18 | 48 | $30,432 | $7,748 | 25.5% |
| 77301 | Management of modulation radiotherapy planning | Facility | 2021 | 16 | 16 | $20,912 | $5,696 | 27.2% |
| 77263 | Management of radiation therapy, complex | Facility | 2021 | 25 | 25 | $13,225 | $3,594 | 27.2% |
| 77338 | Design and construction of device for radiation therapy | Facility | 2021 | 15 | 15 | $11,025 | $2,864 | 26.0% |
| G6002 | Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy | Facility | 2021 | 113 | 154 | $10,010 | $2,659 | 26.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 33 | 33 | $6,237 | $2,633 | 42.2% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 13 | 13 | $4,615 | $2,055 | 44.5% |
| 77300 | Calculation of radiation therapy dose | Facility | 2021 | 25 | 73 | $7,373 | $2,019 | 27.4% |
| 77470 | Special radiation treatment procedure | Facility | 2021 | 22 | 22 | $7,502 | $2,009 | 26.8% |
| 77334 | Radiation treatment devices, design and construction, complex | Facility | 2021 | 23 | 37 | $7,437 | $1,894 | 25.5% |
| 77014 | Ct scan guidance for insertion of radiation therapy fields | Facility | 2021 | 42 | 49 | $6,860 | $1,877 | 27.4% |
About Dr. Abigail Berman, MD
Dr. Abigail Berman, MD is a Radiation Oncology healthcare provider based in Philadelphia, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/18/2009. The National Provider Identifier (NPI) number assigned to this provider is 1235364423.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Abigail Berman, MD has received a total of $26,108 in payments from pharmaceutical and medical device companies, with $18.85 received in 2024. These payments were reported across 14 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($24,947).
As a Medicare-enrolled provider, Berman has provided services to 1,675 Medicare beneficiaries, totaling 2,494 services with total Medicare billing of $199,261. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Practice Information
- Specialty Radiation Oncology
- Other Specialties Radiation Oncology
- Location Philadelphia, PA
- Active Since 05/18/2009
- Last Updated 12/13/2022
- Taxonomy Code 2085R0001X
- Entity Type Individual
- NPI Number 1235364423
Products in Payments
- IMFINZI (Biological) $16,636
- TAGRISSO (Drug) $4,530
- OTHER (Device) $3,782
- TrueBeam (Device) $639.68
- IMBRUVICA (Drug) $18.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Radiation Oncology Doctors in Philadelphia
Neil Taunk, Md, MD
Radiation Oncology — Payments: $179,533
Wenyin Shi, Md, Phd, MD, PHD
Radiation Oncology — Payments: $122,872
Dr. Adam Dicker, M.d, M.D
Radiation Oncology — Payments: $91,500
Kenneth Martin, Md, MD
Radiation Oncology — Payments: $84,766
Dr. Andy Minn, M.d, M.D
Radiation Oncology — Payments: $71,226
Michelle Alonso-Basanta, Md, MD
Radiation Oncology — Payments: $50,995